Positron Corporation (POSC)
USD 1.57
(-16.49%)
USD 1.57
(-16.49%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -1.63 Million USD | 42.68% |
| 2022 | -2.85 Million USD | -380.44% |
| 2021 | -595.07 Thousand USD | -858.7% |
| 2020 | -62.07 Thousand USD | -199.11% |
| 2019 | -20.75 Thousand USD | -265.29% |
| 2018 | 12.55 Thousand USD | 0.0% |
| 2014 | -2.58 Million USD | 63.63% |
| 2013 | -7.1 Million USD | 10.7% |
| 2012 | -7.95 Million USD | -29.96% |
| 2011 | -6.12 Million USD | 43.96% |
| 2010 | -10.92 Million USD | -90.0% |
| 2009 | -5.74 Million USD | 35.94% |
| 2008 | -8.97 Million USD | -15.36% |
| 2007 | -7.78 Million USD | -18.13% |
| 2006 | -6.58 Million USD | -73.04% |
| 2005 | -3.8 Million USD | -129.55% |
| 2004 | -1.65 Million USD | -285.87% |
| 2003 | 892 Thousand USD | 130.06% |
| 2002 | -2.96 Million USD | 19.94% |
| 2001 | -3.7 Million USD | -4675.31% |
| 2000 | 81 Thousand USD | 105.82% |
| 1999 | -1.39 Million USD | -92.13% |
| 1998 | -724 Thousand USD | 83.75% |
| 1997 | -4.45 Million USD | 30.12% |
| 1996 | -6.37 Million USD | -27.5% |
| 1995 | -5 Million USD | -31.58% |
| 1994 | -3.8 Million USD | -15.15% |
| 1993 | -3.3 Million USD | -175.0% |
| 1992 | -1.2 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -555.03 Thousand USD | -25.68% |
| 2023 Q4 | -441.62 Thousand USD | 19.38% |
| 2023 Q1 | -299.45 Thousand USD | -51.88% |
| 2023 Q3 | -547.77 Thousand USD | -56.58% |
| 2023 FY | -1.63 Million USD | 42.68% |
| 2023 Q2 | -349.84 Thousand USD | -16.83% |
| 2022 Q3 | -587.85 Thousand USD | -240.93% |
| 2022 Q1 | -1.35 Million USD | -1231.68% |
| 2022 FY | -2.85 Million USD | -380.44% |
| 2022 Q2 | -172.42 Thousand USD | 87.24% |
| 2022 Q4 | -197.16 Thousand USD | 66.46% |
| 2021 Q4 | 119.43 Thousand USD | 153.36% |
| 2021 Q3 | -223.82 Thousand USD | 2.19% |
| 2021 Q2 | -228.84 Thousand USD | 12.6% |
| 2021 Q1 | -261.83 Thousand USD | 0.0% |
| 2021 FY | -595.07 Thousand USD | -858.7% |
| 2020 FY | -62.07 Thousand USD | -199.11% |
| 2020 Q2 | -24.77 Thousand USD | 0.0% |
| 2019 FY | -20.75 Thousand USD | -265.29% |
| 2018 FY | 12.55 Thousand USD | 0.0% |
| 2015 Q1 | -554 Thousand USD | -544.19% |
| 2015 Q3 | -255 Thousand USD | 32.0% |
| 2015 Q2 | -375 Thousand USD | 32.31% |
| 2014 Q2 | -201 Thousand USD | 76.66% |
| 2014 FY | -2.58 Million USD | 63.63% |
| 2014 Q4 | -86 Thousand USD | 94.01% |
| 2014 Q3 | -1.43 Million USD | -614.43% |
| 2014 Q1 | -861 Thousand USD | 74.88% |
| 2013 Q1 | -1.2 Million USD | 45.16% |
| 2013 Q2 | -1.08 Million USD | 9.41% |
| 2013 FY | -7.1 Million USD | 10.7% |
| 2013 Q3 | -1.39 Million USD | -27.76% |
| 2013 Q4 | -3.42 Million USD | -146.55% |
| 2012 Q3 | -1.56 Million USD | -26.96% |
| 2012 FY | -7.95 Million USD | -29.96% |
| 2012 Q2 | -1.23 Million USD | 58.31% |
| 2012 Q4 | -2.19 Million USD | -39.67% |
| 2012 Q1 | -2.96 Million USD | -169.76% |
| 2011 Q3 | -1.45 Million USD | 48.75% |
| 2011 FY | -6.12 Million USD | 43.96% |
| 2011 Q4 | -1.09 Million USD | 24.43% |
| 2011 Q2 | -2.83 Million USD | -285.71% |
| 2011 Q1 | -735 Thousand USD | 52.85% |
| 2010 Q1 | -3.26 Million USD | -13.17% |
| 2010 FY | -10.92 Million USD | -90.0% |
| 2010 Q3 | 294 Thousand USD | 104.6% |
| 2010 Q4 | -1.55 Million USD | -630.27% |
| 2010 Q2 | -6.39 Million USD | -95.8% |
| 2009 FY | -5.74 Million USD | 35.94% |
| 2009 Q3 | -1.18 Million USD | -27.99% |
| 2009 Q2 | -929 Thousand USD | -24.53% |
| 2009 Q1 | -746 Thousand USD | 86.66% |
| 2009 Q4 | -2.88 Million USD | -142.64% |
| 2008 Q2 | -2.01 Million USD | -83.53% |
| 2008 Q3 | -265 Thousand USD | 86.86% |
| 2008 Q4 | -5.59 Million USD | -2010.94% |
| 2008 Q1 | -1.09 Million USD | 72.86% |
| 2008 FY | -8.97 Million USD | -15.36% |
| 2007 FY | -7.78 Million USD | -18.13% |
| 2007 Q4 | -4.05 Million USD | -169.28% |
| 2007 Q1 | -1.11 Million USD | 32.79% |
| 2007 Q2 | -1.1 Million USD | 1.07% |
| 2007 Q3 | -1.5 Million USD | -35.86% |
| 2006 Q2 | -3.11 Million USD | -169.46% |
| 2006 FY | -6.58 Million USD | -73.04% |
| 2006 Q1 | -1.15 Million USD | 15.25% |
| 2006 Q3 | -649 Thousand USD | 79.17% |
| 2006 Q4 | -1.66 Million USD | -156.55% |
| 2005 FY | -3.8 Million USD | -129.55% |
| 2005 Q4 | -1.36 Million USD | -59.53% |
| 2005 Q2 | -949 Thousand USD | -48.75% |
| 2005 Q3 | -855 Thousand USD | 9.91% |
| 2005 Q1 | -638 Thousand USD | -12.72% |
| 2004 Q1 | -246 Thousand USD | 38.81% |
| 2004 Q3 | -203 Thousand USD | 68.43% |
| 2004 Q4 | -566 Thousand USD | -178.82% |
| 2004 FY | -1.65 Million USD | -285.87% |
| 2004 Q2 | -643 Thousand USD | -161.38% |
| 2003 Q2 | 1.83 Million USD | 14007.69% |
| 2003 Q4 | -402 Thousand USD | 27.31% |
| 2003 FY | 892 Thousand USD | 130.06% |
| 2003 Q3 | -553 Thousand USD | -130.15% |
| 2003 Q1 | 13 Thousand USD | 101.42% |
| 2002 Q4 | -916 Thousand USD | -34.51% |
| 2002 Q1 | -511 Thousand USD | 72.73% |
| 2002 Q2 | -859 Thousand USD | -68.1% |
| 2002 Q3 | -681 Thousand USD | 20.72% |
| 2002 FY | -2.96 Million USD | 19.94% |
| 2001 Q1 | -662 Thousand USD | 33.0% |
| 2001 Q4 | -1.87 Million USD | -230.51% |
| 2001 Q2 | -603 Thousand USD | 8.91% |
| 2001 FY | -3.7 Million USD | -4675.31% |
| 2001 Q3 | -567 Thousand USD | 5.97% |
| 2000 Q3 | 1.53 Million USD | 592.95% |
| 2000 FY | 81 Thousand USD | 105.82% |
| 2000 Q2 | -312 Thousand USD | -98.73% |
| 2000 Q1 | -157 Thousand USD | 0.0% |
| 2000 Q4 | -988 Thousand USD | -164.24% |
| 1999 FY | -1.39 Million USD | -92.13% |
| 1998 FY | -724 Thousand USD | 83.75% |
| 1997 Q1 | -1.3 Million USD | 26.76% |
| 1997 FY | -4.45 Million USD | 30.12% |
| 1996 Q3 | -1 Million USD | 37.5% |
| 1996 Q4 | -1.77 Million USD | -77.5% |
| 1996 FY | -6.37 Million USD | -27.5% |
| 1996 Q2 | -1.6 Million USD | 23.81% |
| 1996 Q1 | -2.1 Million USD | -31.25% |
| 1995 Q2 | -500 Thousand USD | 64.29% |
| 1995 Q1 | -1.4 Million USD | -40.0% |
| 1995 Q4 | -1.6 Million USD | -6.67% |
| 1995 Q3 | -1.5 Million USD | -200.0% |
| 1995 FY | -5 Million USD | -31.58% |
| 1994 Q2 | -1 Million USD | -25.0% |
| 1994 Q1 | -800 Thousand USD | 70.37% |
| 1994 FY | -3.8 Million USD | -15.15% |
| 1994 Q3 | -1 Million USD | 0.0% |
| 1994 Q4 | -1 Million USD | 0.0% |
| 1993 Q3 | -200 Thousand USD | 0.0% |
| 1993 Q2 | -200 Thousand USD | 0.0% |
| 1993 FY | -3.3 Million USD | -175.0% |
| 1993 Q4 | -2.7 Million USD | -1250.0% |
| 1993 Q1 | -200 Thousand USD | 33.33% |
| 1992 Q3 | -300 Thousand USD | 0.0% |
| 1992 Q4 | -300 Thousand USD | 0.0% |
| 1992 FY | -1.2 Million USD | 0.0% |
| 1992 Q1 | -300 Thousand USD | 0.0% |
| 1992 Q2 | -300 Thousand USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| CVR Medical Corp. | - USD | Infinity% |
| BioElectronics Corporation | -722.81 Thousand USD | -126.712% |
| IR-Med Inc. | -4.9 Million USD | 66.618% |
| Polarean Imaging plc | -11.88 Million USD | 86.212% |
| Medical Supply International USA, Inc. | 394.84 Thousand USD | 515.03% |
| Avitar, Inc. | -2.25 Million USD | 27.479% |
| AVITA Medical, Inc. | -39.16 Million USD | 95.816% |
| Manhattan Scientifics, Inc. | -1.16 Million USD | -40.661% |
| Össur hf. | 58.38 Million USD | 102.807% |
| Zecotek Photonics Inc. | -3.51 Million USD | 53.432% |
| QHSLab, Inc. | -468.36 Thousand USD | -249.88% |
| Wellstar International, Inc. | -3.1 Million USD | 47.283% |
| Össur hf. | 58.38 Million USD | 102.807% |
| Bionovate Technologies Corp | - USD | Infinity% |
| EKF Diagnostics Holdings plc | 2.35 Million USD | 169.673% |
| Escalon Medical Corp. | -125.26 Thousand USD | -1208.231% |
| Aurora Spine Corporation | -1.68 Million USD | 2.491% |
| BrainsWay Ltd. | -4.19 Million USD | 60.955% |
| Lattice Biologics Ltd. | - USD | Infinity% |
| NewCardio, Inc. | -11.49 Million USD | 85.746% |
| Hamilton Thorne Ltd. | -607.02 Thousand USD | -169.958% |
| Vivos Inc. | -2.89 Million USD | 43.391% |
| MicroPort Scientific Corporation | -477.62 Million USD | 99.657% |
| Kelyniam Global, Inc. | -218.47 Thousand USD | -650.078% |
| REMSleep Holdings, Inc. | -1.77 Million USD | 7.826% |
| CYduct Diagnostics, Inc. | -418.03 Thousand USD | -292.003% |
| Nanomix Corporation | -12.33 Million USD | 86.713% |
| Theraclion SA | -3.67 Million USD | 55.41% |
| Lifeline Biotechnologies, Inc. | - USD | Infinity% |
| Wellness Center USA, Inc. | -752.98 Thousand USD | -117.629% |
| Rafina Innovations Inc. | - USD | Infinity% |
| Electromedical Technologies, Inc. | -2.64 Million USD | 37.957% |
| Lombard Medical, Inc. | -31.03 Million USD | 94.72% |
| ALR Technologies Inc. | -11.89 Million USD | 86.226% |
| Stratec SE | 14.42 Million USD | 111.359% |
| Vycor Medical, Inc. | -69.69 Thousand USD | -2251.384% |
| Heart Tronics, Inc. | -13.32 Million USD | 87.704% |
| Nu-Med Plus, Inc. | -125.52 Thousand USD | -1205.469% |
| Perimeter Medical Imaging AI, Inc. | -14.03 Million USD | 88.325% |
| SANUWAVE Health, Inc. | -25.8 Million USD | 93.65% |
| VMS Rehab Systems, Inc. | 46.44 USD | 3528745.564% |
| Guided Therapeutics, Inc. | -3.48 Million USD | 53.032% |
| Ingen Technologies, Inc. | -5.06 Million USD | 67.624% |
| Odyssey Group International, Inc. | -905.77 Thousand USD | -80.918% |
| United American Healthcare Corporation | 723 Thousand USD | 326.653% |
| ECGI Holdings, Inc. | -3.61 Million USD | 54.618% |
| Capital Group Holdings, Inc. | -658.02 Thousand USD | -149.034% |
| ADM Tronics Unlimited, Inc. | -716.85 Thousand USD | -128.597% |
| Urologix, Inc. | -7.6 Million USD | 78.461% |
| Rapid Therapeutic Science Laboratories, Inc. | -1.69 Million USD | 3.253% |
| Nexeon MedSystems Inc. | -2.17 Million USD | 24.749% |
| SS Innovations International, Inc. | -20.94 Million USD | 92.175% |
| Qualis Innovations, Inc. | -805.02 Thousand USD | -103.56% |
| Smith & Nephew plc | 263 Million USD | 100.623% |
| NIOX Group Plc | 13.64 Million USD | 112.014% |
| Fuse Medical, Inc. | 1.45 Million USD | 212.243% |
| Broncus Holding Corporation | -28.09 Million USD | 94.166% |
| Brain Scientific Inc. | -12.34 Million USD | 86.725% |
| Pressure BioSciences, Inc. | -29.31 Million USD | 94.41% |
| Health Logic Interactive Inc. | -160.24 Thousand USD | -922.604% |